Literature DB >> 873575

A neutrophil-dependent pathway for the generation of a neutral peptide mediator. II. Subcellular localization of the neutrophil protease.

B U Wintroub, E J Goetzl, K F Austen.   

Abstract

The human neutrophil neutral peptide-generating protease was associated with the plasma membrane marker 5'-nucleotidase on sucrose density gradient centrifugation of sonicates of granule-free fractions following homogenization and velocity sedimentation. The two activities were also associated on sucrose density gradient fractionation of plasma membranes obtained by hypotonic lysis in EDTA containing buffers, a technique which minimizes aggregation. Treatment of fractions containing these enzymatic activities with 1-0 M NaCl separated the neutral peptide-generating proteasein to the eluate while leaving the 5'-nucleotidase in the pellet. Gel filtration of the solubilized neutral peptide-generating protease through Sephadex G-100 in 1-0 M NaCl demonstrated that the protease had an approximate mol. wt of 20,000 while filtration in physiological salt concentrations yielded activity only in the excluded volume. In both cases, there was complete recovery of neutral peptide-generating activity suggesting that the filtration characteristics of the protease were determined by the salt concentration. The solubilized purified protease, the whole cell sonicates, and the intact cells interacted with heat-inactivated plasma to yield the same product, a neutral peptide with a 1000 molecular weight and an isoelectric point of 7-2-7-6. The neutral peptide-generating protease in each instance was inhibited in dose-response fashion by alpha-1-antitrypsin, LBTI, and DFP. Only 30-60% of the protease sites were functional on intact cells as revealed by substrate cleavage or were available to inhibitors. The neutrophil protease which generates neutral peptide is an extrinsic plasma membrane protein with an approximate mol. wt of 20,000 which functions as an ectoenzyme.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 873575      PMCID: PMC1445417     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  7 in total

1.  Serum 5-nucleotidase.

Authors:  T F DIXON; M PURDOM
Journal:  J Clin Pathol       Date:  1954-11       Impact factor: 3.411

2.  Demonstration of a kinin-generating enzyme in the lysosomes of human polymorphonuclear leukocytes.

Authors:  H Z Movat; S G Steinberg; F M Habal; N S Ranadive
Journal:  Lab Invest       Date:  1973-12       Impact factor: 5.662

3.  The purification of human serum 1 -antitrypsin by affinity chromatography on concanavalin A.

Authors:  I E Liener; O R Garrison; Z Pravda
Journal:  Biochem Biophys Res Commun       Date:  1973-03-17       Impact factor: 3.575

4.  Plasma inhibitors of the components of the fibrinolytic pathway in man.

Authors:  A D Schreiber; A P Kaplan; K F Austen
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

5.  The fluid mosaic model of the structure of cell membranes.

Authors:  S J Singer; G L Nicolson
Journal:  Science       Date:  1972-02-18       Impact factor: 47.728

6.  Distribution of lysosomal enzymes, cationic proteins, and bactericidal substances in subcellular fractions of human polymorphonuclear leukocytes.

Authors:  I R Welsh; J K Spitznagel
Journal:  Infect Immun       Date:  1971-08       Impact factor: 3.441

7.  A neutrophil-dependent pathway for the generation of a neutral peptide mediator: partial characterization of components and control by alpha-1-antitrypsin.

Authors:  B U Wintroub; E J Goetzl; K F Austen
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

  7 in total
  3 in total

1.  Purification and characterization of a human neutrophil neutral protease. The neutral peptide-generating protease.

Authors:  J S Coblyn; K F Austen; B U Wintroub
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

2.  Identification of a human neutrophil angiotension II-generating protease as cathepsin G.

Authors:  M G Tonnesen; M S Klempner; K F Austen; B U Wintroub
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

3.  Cleavage of fibrinogen by the human neutrophil neutral peptide-generating protease.

Authors:  B U Wintroub; J S Coblyn; C E Kaempfer; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.